Dr. Nicole Colette Bouchard, MD

Dr. Bouchard practices at Healthalliance Hospital - Broadway Campus (Closed) in Kingston, New York.

Dr. Bouchard's NPI, 1699708883, was assigned on July 9, 2006. Dr. Bouchard holds New York license 002359.

Dr. Bouchard's primary practice is Healthalliance Hospital - Broadway Campus (Closed), at 396 Broadway, Kingston, NY 12401 in Ulster County. The practice phone is (845) 331-3131.

Dr. Bouchard's primary practice is Healthalliance Hospital - Broadway Campus (Closed) in Kingston, New York. The medical group on file is Vituity. Dmand AI also links Dr. Bouchard to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bouchard practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Bouchard's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Bouchard is licensed in New York.

CMS data shows 321 Medicare services from Dr. Bouchard across 4 procedure codes in 2024, for 313 Medicare patients. Medicare paid $42,332 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 313 Medicare patients who saw Dr. Bouchard in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bouchard's median patient age at 52, with 50% women.

In 2024, Dr. Bouchard wrote 144 Medicare Part D claims for 93 patients. 94% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $155 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Bouchard for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 15 papers to Dr. Bouchard, published from 2011 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Akkermansia. Dr. Bouchard has published most often in Curr Oncol. Dr. Bouchard's most frequent co-authors are Andrew M. Thomas, MD, Matthew Dominic Bacchetta, MD and Philip R. Muskin, MD.

Dmand AI links Dr. Bouchard to 2 clinical trials. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 1 general payment to Dr. Bouchard from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $21.